TEVA PHARMACEUTICAL INDUSTRIES LIMITED Effective Tax Rate
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Effective Tax Rate of -14.80% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, percent for the quarter ending 2019-06-30 was 21.00%, a 30.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, percent for the quarter ending 2019-03-31 was 11.00%, a 175.00% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, percent for the quarter ending 2018-09-30 was 12.00%.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, percent for the quarter ending 2018-06-30 was 30.00%.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED effective income tax rate reconciliation, percent for fiscal 2025 was -14.80%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2025-12-31 | -14.80% 10-K · filed 2026-02-03 | |||
| 2019-09-30 | 13.00% 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 21.00% 10-Q · filed 2019-08-07 | 18.00% 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | 11.00% 10-Q · filed 2019-05-02 | |||
| 2018-09-30 | 12.00% 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | 30.00% 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | 4.00% 10-Q · filed 2019-05-02 | |||
| 2017-03-31 | 8.00% 10-Q · filed 2018-05-03 | |||
| 2012-12-31 | -8.00% 20-F · filed 2013-02-12 | |||
| 2011-12-31 | 4.00% 20-F · filed 2013-02-12 | |||
| 2010-12-31 | 8.00% 20-F · filed 2013-02-12 | |||
| 2009-12-31 | 8.00% 20-F · filed 2012-02-17 | |||
| 2008-12-31 | 23.00% 20-F · filed 2011-02-15 |